1. Home
  2. FPF vs ELVN Comparison

FPF vs ELVN Comparison

Compare FPF & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

FPF

First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

HOLD

Current Price

$17.41

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$38.29

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPF
ELVN
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FPF
ELVN
Price
$17.41
$38.29
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$43.40
AVG Volume (30 Days)
124.0K
1.2M
Earning Date
01-01-0001
03-03-2026
Dividend Yield
8.08%
N/A
EPS Growth
N/A
3.17
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.60
$13.30
52 Week High
$19.75
$40.62

Technical Indicators

Market Signals
Indicator
FPF
ELVN
Relative Strength Index (RSI) 28.68 69.51
Support Level N/A $18.04
Resistance Level $18.88 N/A
Average True Range (ATR) 0.30 2.33
MACD -0.07 0.95
Stochastic Oscillator 9.20 75.63

Price Performance

Historical Comparison
FPF
ELVN

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: